UBS(L)Eq.SICAV Ch.H.C(USD)UX a.USD/ LU2389359030 /
| NAV2024-06-04 | Chg.+125.6001 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 7,719.9302USD | +1.65% | reinvestment | Equity Sector Health / Pharma | UBS Fund M. (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | - | - | - | - | - | - | - | - | -15.44 | -7.01 | 23.34 | 7.13 | - |
| 2023 | 10.72 | -9.44 | -3.90 | 0.33 | -7.72 | -2.24 | 5.04 | -5.19 | 1.21 | 3.26 | 2.62 | -5.12 | -11.61% |
| 2024 | -14.46 | 7.71 | -6.42 | 0.92 | -2.28 | 1.72 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 20.31% | 20.10% | 20.72% | -% | -% |
| Sharpe ratio | -1.62 | -1.52 | -0.95 | - | - |
| Best month | +7.71% | +7.71% | +7.71% | - | - |
| Worst month | -14.46% | -14.46% | -14.46% | - | - |
| Maximum loss | -17.05% | -19.04% | -23.26% | - | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| UBS(L)Eq.SICAV Ch.H.C(USD)Q a.US... | reinvestment | 59.6800 | -16.95% | - | |
| UBS(L)Eq.SICAV Ch.H.C(USD)P a.US... | reinvestment | 58.4100 | -17.66% | - | |
| UBS(L)Eq.SICAV Ch.H.C(USD)UX a.U... | reinvestment | 7,719.9302 | -15.85% | - |
Performance
| YTD | -13.52% | ||
|---|---|---|---|
| 6 Months | -14.43% | ||
| 1 Year | -15.85% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -22.46% | ||
| Year | |||
| 2023 | -11.61% | ||
